Calciva D3
Calciva D3 Uses, Dosage, Side Effects, Food Interaction and all others data.
Vitamin D is essential for normal bone growth and development and to maintain bone density. It is also necessary for utilization of both Calcium and Phosphorus. Vitamin D acts as a hormone and increases reabsorption of Calcium and Phosphorus by the kidneys and increased bone turnover.
The in vivo synthesis of the predominant two biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of vitamin D3 cholecalciferol (or D2) occurs in the liver to yield 25-hydroxyvitamin D while the second hydroxylation happens in the kidneys to give 1, 25-dihydroxyvitamin D . These vitamin D metabolites subsequently facilitate the active absorption of calcium and phosphorus in the small intestine, serving to increase serum calcium and phosphate levels sufficiently to allow bone mineralization . Conversely, these vitamin D metabolites also assist in mobilizing calcium and phosphate from bone and likely increase the reabsorption of calcium and perhaps also of phosphate via the renal tubules . There exists a period of 10 to 24 hours between the administration of cholecalciferol and the initiation of its action in the body due to the necessity of synthesis of the active vitamin D metabolites in the liver and kidneys . It is parathyroid hormone that is responsible for the regulation of such metabolism at the level of the kidneys .
Trade Name | Calciva D3 |
Availability | Rx and/or OTC |
Generic | Cholecalciferol |
Cholecalciferol Other Names | Calciol, Cholecalciferol, Cholecalciferolum, Colecalciferol, Colecalciferolum, Oleovitamin D3, Vitamin D-3, Vitamin D3 |
Related Drugs | Vitamin D3, ergocalciferol, Drisdol, D3, D3-50, Enfamil D-Vi-Sol, Replesta, Carlson D |
Type | Tablet |
Formula | C27H44O |
Weight | Average: 384.6377 Monoisotopic: 384.33921603 |
Protein binding | The protein binding documented for cholecalciferol is 50 to 80% . Specifically, in the plasma, vitamin D3 (from either diet or the skin) is bound to vitamin D-binding protein (DBP) produced in the liver, for transport to the liver. Ultimately, the form of vitamin D3 reaching the liver is 25-hydroxylated, and such 25-hydroxycholecalciferol is bound to DBP (α2-globulin) whilst circulating in the plasma . |
Groups | Approved, Nutraceutical |
Therapeutic Class | Vitamin in bone formation, Vitamin-D preparations |
Manufacturer | Gnova Biotech |
Available Country | India |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Vitamin D is used to treat and prevent bone disorders (such as rickets, osteomalacia). Vitamin D is made by the body when skin is exposed to sunlight. Sunscreen, protective clothing, limited exposure to sunlight, dark skin, and age may prevent getting enough vitamin D from the sun.
Vitamin D with calcium is used to treat or prevent bone loss (osteoporosis). Vitamin D is also used with other medications to treat low levels of calcium or phosphate caused by certain disorders (such as hypoparathyroidism, pseudohypoparathyroidism, familial hypophosphatemia). It may be used in kidney disease to keep calcium levels normal and allow normal bone growth.
Calciva D3 is also used to associated treatment for these conditions: Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Fracture Bone, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture, Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation
How Calciva D3 works
Most individuals naturally generate adequate amounts of vitamin D through ordinary dietary intake of vitamin D (in some foods like eggs, fish, and cheese) and natural photochemical conversion of the vitamin D3 precursor 7-dehydrocholesterol in the skin via exposure to sunlight .
Conversely, vitamin D deficiency can often occur from a combination of insufficient exposure to sunlight, inadequate dietary intake of vitamin D, genetic defects with endogenous vitamin D receptor, or even severe liver or kidney disease . Such deficiency is known for resulting in conditions like rickets or osteomalacia, all of which reflect inadequate mineralization of bone, enhanced compensatory skeletal demineralization, resultant decreased calcium ion blood concentrations, and increases in the production and secretion of parathyroid hormone . Increases in parathyroid hormone stimulate the mobilization of skeletal calcium and the renal excretion of phosphorus . This enhanced mobilization of skeletal calcium leads towards porotic bone conditions .
Ordinarily, while vitamin D3 is made naturally via photochemical processes in the skin, both itself and vitamin D2 can be found in various food and pharmaceutical sources as dietary supplements. The principal biological function of vitamin D is the maintenance of normal levels of serum calcium and phosphorus in the bloodstream by enhancing the efficacy of the small intestine to absorb these minerals from the diet . At the liver, vitamin D3 or D2 is hydroxylated to 25-hydroxyvitamin D and then finally to the primary active metabolite 1,25-dihydroxyvitamin D in the kidney via further hydroxylation . This final metabolite binds to endogenous vitamin d receptors, which results in a variety of regulatory roles - including maintaining calcium balance, the regulation of parathyroid hormone, the promotion of the renal reabsorption of calcium, increased intestinal absorption of calcium and phosphorus, and increased calcium and phosphorus mobilization of calcium and phosphorus from bone to plasma to maintain balanced levels of each in bone and the plasma .
In particular, calcitriol interacts with vitamin D receptors in the small intestine to enhance the efficiency of intestinal calcium and phosphorous absorption from about 10-15% to 30-40% and 60% increased to 80%, respectively . Furthermore, calcitriol binds with vitamin D receptors in osteoblasts to stimulate a receptor activator of nuclear factor kB ligand (or RANKL) which subsequently interacts with receptor activator of nuclear factor kB (NFkB) on immature preosteoclasts, causing them to become mature bone-resorbing osteoclasts . Such mature osteoclasts ultimately function in removing calcium and phosphorus from bone to maintain blood calcium and phosphorus levels . Moreover, calcitriol also stimulates calcium reabsorption from the glomerular filtrate in the kidneys .
Additionally, it is believed that when calcitriol binds with nuclear vitamin D receptors, that this bound complex itself binds to retinoic acid X receptor (RXR) to generate a heterodimeric complex that consequently binds to specific nucleotide sequences in the DNA called vitamin D response elements . When bound, various transcription factors attach to this complex, resulting in either up or down-regulation of the associated gene's activity. It is thought that there may be as much as 200 to 2000 genes that possess vitamin D response elements or that are influenced indirectly to control a multitude of genes across the genome . It is in this way that cholecalciferol is believed to function in regulating gene transcription associated with cancer risk, autoimmune disorders, and cardiovascular disease linked to vitamin D deficiency . In fact, there has been some research to suggest calcitriol may also be able to prevent malignancies by inducing cellular maturation and inducing apoptosis and inhibiting angiogenesis, exhibit anti-inflammatory effects by inhibiting foam cell formation and promoting angiogenesis in endothelial colony-forming cells in vitro, inhibit immune reactions by enhancing the transcription of endogenous antibiotics like cathelicidin and regulate the activity and differentiation of CD4+ T cells, amongst a variety of other proposed actions .
Dosage
Calciva D3 dosage
Oral solution: Colecalciferol (Vitamin D3) is recommended 5-10 mcg or 1-2ml (200-400 IU)/day or as directed by the physician.
Chewable tablet: Calciva D3 (Vitamin D3) is recommended 100 IU (1 tablet) daily, or as directed by physician. Take the medicine with food or within 1 hour after a meal. Place the tablet in mouth swallow after chewing.
Injection:
- Treatment of Calciva D3 deficiency: 40,000 lU/week for 7 weeks, followed by maintenance therapy (1400-2000 lU/day). Follow-up 25 (OH) D measurements should be made approximately 3 to 4 months after initiating maintenance therapy to confirm that the target level has been achieved.
- Prevention of Vitamin D deficiency: 20,000 lU/Month.
- Treatment of Vitamin D deficiency:12-18 years: 20,000 IU, once every 2 weeks for 6 weeks. Prevention of Vitamin D deficiency, 12-18 years: 20,000 IU, once every 6 weeks.
Side Effects
Generally all nutritional supplements are considered to be safe and well tolerable. However, few side-effects can generally occur including hypercalcaemia syndrome or Calcium intoxication (depending on the severity and duration of hypercalcaemia), occasional acute symptoms include anorexia, headache, nausea, vomiting, abdominal pain or stomach ache and constipation with the administration of Colecaciferol.
Toxicity
Chronic or acute administration of excessive doses of cholecalciferol may lead to hypervitaminosis D, manifested by hypercalcemia and its sequelae . Early symptoms of hypercalcemia may include weakness, fatigue, somnolence, headache, anorexia, dry mouth, metallic taste, nausea, vomiting, vertigo, tinnitus, ataxia, and hypotonia . Later and possibly more serious manifestation include nephrocalcinosis, renal dysfunction, osteoporosis in adults, impaired growth in children, anemia, metastatic calcification, pancreatitis, generalized vascular calcification, and seizures .
Safety of doses in excess of 400 IU (10mcg) of vitamin D3 daily during pregnancy has not been established . Maternal hypercalcemia, possibly caused by excessive vitamin D intake during pregnancy, has been associated with hypercalcemia in neonates, which may lead to supravalvular aortic stenosis syndrome, the features of which may include retinopathy, mental or growth retardation, strabismus, and other effects . Hypercalcemia during pregnancy may also lead to suppression of parathyroid hormone release in the neonate, resulting in hypocalcemia, tetany, and seizures .
Vitamin D is deficient in maternal milk; therefore, breastfed infants may require supplementation. Use of excessive amounts of Vitamin D in nursing mothers may result in hypercalcemia in infants. Doses of Vitamin D3 in excess of 10 µg daily should not be administered daily to nursing women.
Precaution
People with the following conditions should exercise caution when considering taking vitamin D supplements: High blood Calcium or Phosphorus level, Heart problems, Kidney disease.
Vitamin D must be taken with adequate amounts of both Calcium and Magnesium supplementation. When Calcium level is low (due to insufficient vitamin D and calcium intake), the body activates the parathyroid gland, which produces PTH (parathyroid hormone). This hormone kick starts vitamin D hormone production and assists removal of Calcium from the bones to be used in more important functions such as neutralizing body acidity.
Interaction
Calciva D3 is known to interact with Carbamazepine, Dactinomycin, Diuretics, Fosphenytoin, Miconazole, Phenobarbital, Phenytoin, Primidone
Food Interaction
No interactions found.Calciva D3 Drug Interaction
Unknown: aspirin, aspirin, aspirin, aspirin, duloxetine, duloxetine, omega-3 polyunsaturated fatty acids, omega-3 polyunsaturated fatty acids, pregabalin, pregabalin, metoprolol, metoprolol, levothyroxine, levothyroxine, acetaminophen, acetaminophen, cyanocobalamin, cyanocobalamin, ascorbic acid, ascorbic acid
Calciva D3 Disease Interaction
Major: arrhythmia, electrolyte imbalance, hypercalcemia, renal dysfunctionModerate: hepatobiliary dysfunction
Volume of Distribution
Studies have determined that the mean central volume of distribution of administered cholecalciferol supplementation in a group of 49 kidney transplant patients was approximately 237 L .
Elimination Route
Calciva D3 is readily absorbed from the small intestine if fat absorption is normal . Moreover, bile is necessary for absorption as well .
In particular, recent studies have determined aspects about the absorption of vitamin D, like the fact that a) the 25-hydroxyvitamin D metabolite of cholecalciferol is absorbed to a greater extent than the nonhydroxy form of cholecalciferol, b) the quantity of fat with which cholecalciferol is ingested does not appear to largely affect its bioavailability, and c) age does not apparently effect vitamin D cholecalciferol .
Half Life
At this time, there have been resources that document the half-life of cholecalciferol as being about 50 days while other sources have noted that the half-life of calcitriol (1,25-dihydroxyvitamin D3) is approximately 15 hours while that of calcidiol (25-hydroxyvitamin D3) is about 15 days .
Moreover, it appears that the half-lives of any particular administration of vitamin d can vary due to variations in vitamin d binding protein concentrations and genotype in particular individuals .
Clearance
Studies have determined that the mean clearance value of administered cholecalciferol supplementation in a group of 49 kidney transplant patients was approximately 2.5 L/day .
Elimination Route
It has been observed that administered cholecalciferol and its metabolites are excreted primarily in the bile and feces .
Pregnancy & Breastfeeding use
There is no evidence to suggest that vitamin D is teratogenic in humans even at very high doses. Colecalciferol should be used during pregnancy only if the benefits outweigh the potential risk to the fetus.
It should be assumed that exogenous Colecalciferol passes into the breast milk. In view of the potential for hypercalcaemia in the mother and for adverse reactions from Colecalciferol in nursing infants, mothers may breastfeed while taking Colecalciferol, provided that the serum Calcium levels of the mother and infant are monitored.
Contraindication
Colecalciferol is contraindicated in all diseases associated with hypercalcaemia. It is also contraindicated in patients with known hypersensitivity to Colecalciferol (or medicines of the same class) and any of the constituent excipients. Colecalciferol is contraindicated if there is evidence of vitamin D toxicity.
Acute Overdose
Symptoms: anorexia, headache, vomiting, constipation, dystrophy (weakness, loss of weight), sensory disturbances, possibly fever with thirst, polyuria, dehydration, apathy, arrested growth and urinary tract infections. Hypercalcaemia ensues, with metastatic calcification of the renal cortex, myocardium, lungs and pancreas.
Treatment: Immediate gastric lavage or induction of vomiting to prevent further absorption. Liquid paraffin should be administered to promote faecal excretion. Repeated serum calcium determinations are advisable. If elevated calcium levels persist in the serum, phosphates and corticosteroids may be administered and measures instituted to bring about adequate diuresis.
Innovators Monograph
You find simplified version here Calciva D3
Calciva D3 contains Cholecalciferol see full prescribing information from innovator Calciva D3 Monograph, Calciva D3 MSDS, Calciva D3 FDA label
FAQ
What is Calciva D3 used for?
Calciva D3 used to treat vitamin D deficiency. It is also used with calcium to maintain bone strength.
How safe is Calciva D3?
You should not use Calciva D3 if you have had an allergic reaction to vitamin D, or if you have high levels of vitamin D in your body, high levels of calcium in your blood or any condition that makes it hard for your body to absorb nutrients from food.
How does Calciva D3 work?
Calciva D3 actions is to increase the uptake of calcium by the intestines.
What are the common side effects of Calciva D3?
Common side effects of Calciva D3 are include:
- chest pain, feeling short of breath;
- growth problems (in a child taking cholecalciferol); or.
- early signs of vitamin D overdose --weakness, metallic taste in your mouth, weight loss, muscle or bone pain, constipation, nausea, and vomiting.
Is Calciva D3 safe during pregnancy?
Calciva D3 use is not recommended unless there is a deficiency.
Is Calciva D3 safe during breastfeeding?
Calciva D3 use is not recommended unless the clinical condition of the woman requires treatment.
Can I drink alcohol with Calciva D3?
No interactions were found between Alcohol and Vitamin D3. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
When should Calciva D3 be taken?
Calciva D3 should be taken as soon as you get out of bed in the morning and at least 30 minutes before any food, beverage, or other medicines.
How long does it take for Calciva D3 to work?
Calciva D3 may take up to 2 to 3 months to bring levels of vitamin D up, depending on how deficient you are.The recommended daily allowance of vitamin D in the United States is 600 IUs for adults up to age 70 and 800 IUs after age 70.
How long does Calciva D3 stay in my system?
There are several metabolic products or modified versions of Calciva D3.Calciva D3 has a half-life of about 15 hours, while Calciva D3 has a half-life of about 15 days.
Can I take Calciva D3 for long term?
Research suggests that long-term Calciva D3 supplementation reduces the risk of multiple sclerosis.Calciva D3 supplements are used to treat adults with severe Calciva D3 deficiency, resulting in loss of bone mineral content, bone pain, muscle weakness and soft bones.
Can Calciva D3 be taken daily?
Most experts recommend that you shouldn't take more than 4,000 IU of Calciva D3 a day.
Who should not take Calciva D3?
You should not take Calciva D3 if you have had an allergic reaction to Calciva D3, or if you have high levels of calcium or Calciva D3 in your body, or any condition that makes it hard for your body to absorb nutrients from food.
How should I take Calciva D3?
It may be best to take Calciva D3 after a meal, but you may take this medicine with or without food.Measure liquid medicine carefully. Use the dosing syringe provided, or use a medicine dose-measuring device.The chewable tablet must be chewed before you swallow it.
What happens if I miss a dose?
Take Calciva D3 as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.
What happens if I overdose of Calciva D3?
Seek emergency medical attention2. An overdose of Calciva D3 can cause serious or life-threatening side effects.Overdose symptoms may include nausea, loss of appetite, thirst, urinating more or less than usual, body aches, stiffness, confusion, or irregular heartbeats.
What happen If I stop taking Calciva D3?
Your doctor will likely advise you to stop taking Calciva D3 supplements immediately. They may also recommend that you reduce the amount of calcium in your diet temporarily.
When should I take Calciva D3 morning or night?
Many people prefer to take supplements such as Calciva D3 first thing in the morning. Not only is it often more convenient, but it's also easier to remember your vitamins in the morning than later in the day.
Is Calciva D3 good for my skin?
Calciva D3 plays an integral role in skin protection and rejuvenation.
Can Calciva D3 cause skin issues?
You may experience red, dry and itchy skin due to Calciva D3 deficiency. Intake of Calciva D3 can help you treat such skin problems. It can also reduce skin rashes.
Can Calciva D3 causes my liver?
There is no evidence that Calciva D3 causes injury to the liver.
Can Calciva D3 affect my kidneys?
Calciva D3 has been reported to have a wide range of benefits. However, a recent case study indicates that excessive use of Calciva D3 can cause kidney damage in people who are not deficient in the vitamin.